These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1221 related articles for article (PubMed ID: 31300015)

  • 1. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
    Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
    J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway.
    Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX
    Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA SPRY4-IT1 regulates breast cancer cell stemness through competitively binding miR-6882-3p with TCF7L2.
    Song X; Zhang X; Wang X; Chen L; Jiang L; Zheng A; Zhang M; Zhao L; Wei M
    J Cell Mol Med; 2020 Jan; 24(1):772-784. PubMed ID: 31736268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA lung cancer associated transcript 1 promotes proliferation and invasion of clear cell renal cell carcinoma cells by negatively regulating miR-495-3p.
    Wang LN; Zhu XQ; Song XS; Xu Y
    J Cell Biochem; 2018 Sep; 119(9):7599-7609. PubMed ID: 29932248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2.
    Chen Y; Wu N; Liu L; Dong H; Liu X
    J Cell Mol Med; 2020 Jul; 24(13):7353-7369. PubMed ID: 32558224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncCCAT1 Promotes Breast Cancer Stem Cell Function through Activating WNT/β-catenin Signaling.
    Tang T; Guo C; Xia T; Zhang R; Zen K; Pan Y; Jin L
    Theranostics; 2019; 9(24):7384-7402. PubMed ID: 31695775
    [No Abstract]   [Full Text] [Related]  

  • 7. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
    Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
    BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.
    Ren L; Chen H; Song J; Chen X; Lin C; Zhang X; Hou N; Pan J; Zhou Z; Wang L; Huang D; Yang J; Liang Y; Li J; Huang H; Jiang L
    Theranostics; 2019; 9(2):449-465. PubMed ID: 30809286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway.
    Yang XZ; Cheng TT; He QJ; Lei ZY; Chi J; Tang Z; Liao QX; Zhang H; Zeng LS; Cui SZ
    Mol Cancer; 2018 Aug; 17(1):126. PubMed ID: 30134915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
    Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
    Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15.
    Liu Y; Cheng T; Du Y; Hu X; Xia W
    BMC Mol Cell Biol; 2020 Sep; 21(1):69. PubMed ID: 32998707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA HOTTIP facilitates the stemness of breast cancer via regulation of miR-148a-3p/WNT1 pathway.
    Han L; Yan Y; Zhao L; Liu Y; Lv X; Zhang L; Zhao Y; Zhao H; He M; Wei M
    J Cell Mol Med; 2020 Jun; 24(11):6242-6252. PubMed ID: 32307830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA NCK1-AS1 exerts oncogenic property in gastric cancer by targeting the miR-22-3p/BCL9 axis to activate the Wnt/β-catenin signaling.
    Guan B; Ma J; Yang Z; Yu F; Yao J
    Environ Toxicol; 2021 Aug; 36(8):1640-1653. PubMed ID: 33974352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis.
    Lu G; Li Y; Ma Y; Lu J; Chen Y; Jiang Q; Qin Q; Zhao L; Huang Q; Luo Z; Huang S; Wei Z
    J Exp Clin Cancer Res; 2018 Nov; 37(1):289. PubMed ID: 30482236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway.
    Zhang M; Wang Y; Jiang L; Song X; Zheng A; Gao H; Wei M; Zhao L
    J Exp Clin Cancer Res; 2021 Jan; 40(1):41. PubMed ID: 33494806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
    Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
    Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation.
    Cheng S; Huang Y; Lou C; He Y; Zhang Y; Zhang Q
    Cancer Biol Ther; 2019; 20(3):328-337. PubMed ID: 30336071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of lncRNA BLACAT1 inhibits ovarian cancer progression by suppressing the Wnt/β-catenin signaling pathway via regulating miR-519d-3p.
    Yang H; Qi Y; Wang XL; Gu JJ; Shi TM
    Mol Cell Biochem; 2020 Apr; 467(1-2):95-105. PubMed ID: 32095930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA BANCR Promotes Pancreatic Cancer Tumorigenesis via Modulating MiR-195-5p/Wnt/β-Catenin Signaling Pathway.
    Wu X; Xia T; Cao M; Zhang P; Shi G; Chen L; Zhang J; Yin J; Wu P; Cai B; Lu Z; Miao Y; Jiang K
    Technol Cancer Res Treat; 2019; 18():1533033819887962. PubMed ID: 31769353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel tumor suppressor ASMTL-AS1 regulates the miR-1228-3p/SOX17/β-catenin axis in triple-negative breast cancer.
    Sun J; Li X; Yu E; Liu J; Sun L; He Q; Lu Q
    Diagn Pathol; 2021 May; 16(1):45. PubMed ID: 34006305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.